Difference between revisions of "Main Page"

From HemOnc.org - A Hematology Oncology Wiki
Jump to navigation Jump to search
m (formatting)
Line 2: Line 2:
 
<!--Hides title of Main Page-->
 
<!--Hides title of Main Page-->
 
<div style="text-align:center">
 
<div style="text-align:center">
−
='''HemOnc.org - A Free Hematology/Oncology Reference'''=
+
<h1>'''HemOnc.org - A Free Hematology/Oncology Reference'''</h1>
 
</div>
 
</div>
−
{| border="1"; style="text-align:center; margin-left: auto; margin-right: auto; font-size:125%; font-weight: bold;"
+
 
 +
{| border="1"; style="text-align:center; margin-left: auto; margin-right: auto; font-size:125%; font-weight: bold; width: 100%;"
 +
|-
 +
|colspan="4" style="background-color:#505050"|
 +
|-
 +
|colspan="2" style="background-color:#66FF66"|'''[[Tutorial#Regimens|Regimens]]: {{#ask: [[Regimen::+]] |?Regimen |limit=10000|format=sum}}'''
 +
|colspan="2" style="background-color:#66CCFF"|'''[[Tutorial#Variant|Regimen variants]]: {{#ask: [[Variant::+]] |?Variant |limit=10000|format=sum}}'''
 +
|-
 +
|colspan="4" style="background-color:#505050"|
 
|-
 
|-
−
|colspan="2" style="background-color:#66FF66"|'''Regimens: {{#ask: [[Regimen::+]] |?Regimen |limit=10000|format=sum}}'''
+
|style="background-color:#F0F0F0"|Jump to:
−
|colspan="2" style="background-color:#66CCFF"|'''Regimen variants: {{#ask: [[Variant::+]] |?Variant |limit=10000|format=sum}}'''
+
|style="background-color:#F0F0F0"|[[#solidtumors|Solid Tumors]]
 +
|style="background-color:#F0F0F0"|[[#malignantheme|Malignant Hematology]]
 +
|style="background-color:#F0F0F0"|[[#otherheme|Other Hematology]]
 +
|-
 +
|colspan="4" background-color:#FFFFE0"|<big>[[Editorial Board]]</big>
 +
|-
 +
|style="background-color:#F0F0F0"|[[:Category:Disease index|Disease index]]
 +
|style="background-color:#F0F0F0"|[[:Category:Drug index|Drug index]]
 +
|style="background-color:#F0F0F0"|[[:Category:Regimen index|Regimen index]]
 +
|style="background-color:#F0F0F0"|[[:Category:General reference pages|General reference]]
 
|-
 
|-
 
|'''[https://hemonc.org/w/index.php?title=Main_Page&mobileaction=toggle_view_desktop Desktop Version]'''
 
|'''[https://hemonc.org/w/index.php?title=Main_Page&mobileaction=toggle_view_desktop Desktop Version]'''
Line 13: Line 30:
 
|'''[[How to add HemOnc.org to your home screen | Mobile shortcut]]'''
 
|'''[[How to add HemOnc.org to your home screen | Mobile shortcut]]'''
 
|'''[[Hematology Oncology Fellowship Programs Directory|Fellowship programs]]'''
 
|'''[[Hematology Oncology Fellowship Programs Directory|Fellowship programs]]'''
−
|-
 
−
|colspan="4" background-color:#FFFFE0"|[[Editorial Board]]
 
−
|-
 
−
|background-color:#F0F8FF"|[[:Category:Disease index|Disease index]]
 
−
|background-color:#F0F8FF"|[[:Category:Drug index|Drug index]]
 
−
|background-color:#F0F8FF"|[[:Category:Regimen index|Regimen index]]
 
−
|background-color:#F0F8FF"|[[:Category:General reference pages|General reference]]
 
 
|}  
 
|}  
  
Line 25: Line 35:
  
 
==Links to Main Disease Pages==
 
==Links to Main Disease Pages==
−
{| border="1" style="text-align:center; margin-left: auto; margin-right: auto; font-weight: bold;"
+
<span id="solidtumors"></span>
 +
{| border="1" style="text-align:center; margin-left: auto; margin-right: auto; font-weight: bold; width: 100%;"
 
!colspan="4" align="center" style="color:white; font-size:150%; background-color:#00008B"| '''Solid Tumors'''
 
!colspan="4" align="center" style="color:white; font-size:150%; background-color:#00008B"| '''Solid Tumors'''
 
|-
 
|-
−
|colspan="4" style="background-color:#93cdff"|'''Site-specific'''
+
|colspan="4" style="background-color:#93cdff"|'''Breast Oncology'''
 
|-
 
|-
−
|style="background-color:#F0F8FF"|[[Anal cancer]]
+
|colspan="2" style="background-color:#F0F8FF"|[[Breast cancer]]
−
|style="background-color:#F0F8FF"|[[Bladder cancer]]
+
|colspan="2" style="background-color:#F0F8FF"|[[Breast cancer, HER-2 positive]]
−
|style="background-color:#F0F8FF"|[[Bone cancer]]
+
|-
−
|style="background-color:#F0F8FF"|[[Breast cancer]]
+
|colspan="4" style="background-color:#93cdff"|'''Dermatologic Oncology'''
 
|-
 
|-
−
|style="background-color:#F0F8FF"|[[Breast cancer, HER-2 positive]]
+
|style="background-color:#F0F8FF"|[[Melanoma]]  
−
|style="background-color:#F0F8FF"|[[Central nervous system (CNS) cancer]]
+
|style="background-color:#F0F8FF"|[[Basal cell and squamous cell skin cancer | Skin, basal & squamous cancer]]
−
|style="background-color:#F0F8FF"|[[Cervical cancer]]
+
|style="background-color:#F0F8FF"|[[Merkel cell carcinoma]]  
−
|style="background-color:#F0F8FF"|[[Colon cancer]]
+
|style="background-color:#F0F8FF"|
 
|-
 
|-
−
|style="background-color:#F0F8FF"|[[Esophageal cancer]]
+
|colspan="4" style="background-color:#93cdff"|'''Endocrine Oncology'''
−
|style="background-color:#F0F8FF"|[[Ewing's sarcoma]]
 
−
|style="background-color:#F0F8FF"|[[Gastric cancer]]
 
−
|style="background-color:#F0F8FF"|[[Gastrointestinal stromal tumor|Gastrointestinal stromal tumor (GIST)]]
 
 
|-
 
|-
 
|style="background-color:#F0F8FF"|[[Germ cell tumors]]
 
|style="background-color:#F0F8FF"|[[Germ cell tumors]]
−
|style="background-color:#F0F8FF"|[[Glioblastoma]]
+
|style="background-color:#F0F8FF"|[[Neuroendocrine tumors]]
−
|style="background-color:#F0F8FF"|[[Head and neck cancer]]
+
|style="background-color:#F0F8FF"|[[Thyroid cancer]]
−
|style="background-color:#F0F8FF"|[[Hepatobiliary cancer]]
+
|style="background-color:#F0F8FF"|
 +
|-
 +
|colspan="4" style="background-color:#93cdff"|'''Gastrointestinal Oncology'''
 +
|-
 +
|style="width: 25%; background-color:#F0F8FF"|[[Anal cancer]]
 +
|style="width: 25%; background-color:#F0F8FF"|[[Colon cancer]]
 +
|style="width: 25%; background-color:#F0F8FF"|[[Esophageal cancer]]
 +
|style="width: 25%; background-color:#F0F8FF"|[[Gastric cancer]]
 
|-
 
|-
−
|style="background-color:#F0F8FF"|[[Non-small cell lung cancer | Lung cancer, non-small cell (NSCLC)]]
+
|style="width: 25%; background-color:#F0F8FF"|[[Gastrointestinal stromal tumor|Gastrointestinal stromal tumor (GIST)]]
−
|style="background-color:#F0F8FF"|[[Small cell lung cancer | Lung cancer, small cell (SCLC)]]
+
|style="width: 25%; background-color:#F0F8FF"|[[Hepatobiliary cancer]]
−
|style="background-color:#F0F8FF"|[[Melanoma]]  
+
|style="width: 25%; background-color:#F0F8FF"|[[Pancreatic cancer]]  
−
|style="background-color:#F0F8FF"|[[Merkel cell carcinoma]]  
+
|style="width: 25%; background-color:#F0F8FF"|[[Rectal cancer]]
 
|-
 
|-
−
|style="background-color:#F0F8FF"|[[Mesothelioma]]
+
|colspan="4" style="background-color:#93cdff"|'''Genitourinary Oncology'''
−
|style="background-color:#F0F8FF"|[[Neuroblastoma]]
 
−
|style="background-color:#F0F8FF"|[[Neuroendocrine tumors]]
 
−
|style="background-color:#F0F8FF"|[[Osteosarcoma]]
 
 
|-
 
|-
−
|style="background-color:#F0F8FF"|[[Ovarian cancer]]
+
|style="background-color:#F0F8FF"|[[Bladder cancer]]
−
|style="background-color:#F0F8FF"|[[Pancreatic cancer]]  
+
|style="background-color:#F0F8FF"|[[Germ cell tumors]]
 
|style="background-color:#F0F8FF"|[[Penile cancer]]
 
|style="background-color:#F0F8FF"|[[Penile cancer]]
 
|style="background-color:#F0F8FF"|[[Prostate cancer]]
 
|style="background-color:#F0F8FF"|[[Prostate cancer]]
 
|-
 
|-
−
|style="background-color:#F0F8FF"|[[Rectal cancer]]
 
 
|style="background-color:#F0F8FF"|[[Renal cancer|Renal cancer (RCC)]]
 
|style="background-color:#F0F8FF"|[[Renal cancer|Renal cancer (RCC)]]
 +
|style="background-color:#F0F8FF"|[[Testicular cancer]]
 +
|style="background-color:#F0F8FF"|
 +
|style="background-color:#F0F8FF"|
 +
|-
 +
|colspan="4" style="background-color:#93cdff"|'''Gynecologic Oncology'''
 +
|-
 +
|style="background-color:#F0F8FF"|[[Cervical cancer]]
 +
|style="background-color:#F0F8FF"|[[Germ cell tumors]]
 +
|style="background-color:#F0F8FF"|[[Ovarian cancer]]
 +
|style="background-color:#F0F8FF"|[[Uterine cancer]]
 +
|-
 +
|colspan="4" style="background-color:#93cdff"|'''Head & Neck Oncology'''
 +
|-
 +
|colspan="2" style="background-color:#F0F8FF"|[[Head and neck cancer]]
 +
|colspan="2" style="background-color:#F0F8FF"|[[Thyroid cancer]]
 +
|-
 +
|colspan="4" style="background-color:#93cdff"|'''Neuro-Oncology'''
 +
|-
 +
|style="background-color:#F0F8FF"|[[Central nervous system (CNS) cancer]]
 +
|style="background-color:#F0F8FF"|[[Glioblastoma]]
 +
|style="background-color:#FFF0F5"|[[CNS leukemia]]
 +
|style="background-color:#FFF0F5"|[[CNS lymphoma]]
 +
|-
 +
|colspan="4" style="background-color:#93cdff"|'''Pediatric Oncology'''
 +
|-
 +
|colspan="4" style="background-color:#F0F8FF"|[[Neuroblastoma]]
 +
|-
 +
|colspan="4" style="background-color:#93cdff"|'''Sarcoma'''
 +
|-
 +
|style="background-color:#F0F8FF"|[[Bone cancer]]
 +
|style="background-color:#F0F8FF"|[[Ewing's sarcoma]]
 +
|style="background-color:#F0F8FF"|[[Gastrointestinal stromal tumor|Gastrointestinal stromal tumor (GIST)]]
 +
|style="background-color:#F0F8FF"|[[Osteosarcoma]]
 +
|-
 
|style="background-color:#F0F8FF"|[[Sarcoma]]  
 
|style="background-color:#F0F8FF"|[[Sarcoma]]  
−
|style="background-color:#F0F8FF"|[[Basal cell and squamous cell skin cancer | Skin, basal & squamous cancer]]
+
|style="background-color:#F0F8FF"|
 +
|style="background-color:#F0F8FF"|
 +
|style="background-color:#F0F8FF"|
 +
|-
 +
|colspan="4" style="background-color:#93cdff"|'''Thoracic Oncology'''
 +
|-
 +
|style="background-color:#F0F8FF"|[[Esophageal cancer]]
 +
|style="background-color:#F0F8FF"|[[Non-small cell lung cancer | Lung cancer, non-small cell (NSCLC)]]
 +
|style="background-color:#F0F8FF"|[[Small cell lung cancer | Lung cancer, small cell (SCLC)]]
 +
|style="background-color:#F0F8FF"|[[Mesothelioma]]
 
|-
 
|-
−
|style="background-color:#F0F8FF"|[[Testicular cancer]]
 
 
|style="background-color:#F0F8FF"|[[Thymoma]]
 
|style="background-color:#F0F8FF"|[[Thymoma]]
−
|style="background-color:#F0F8FF"|[[Thyroid cancer]]
+
|style="background-color:#F0F8FF"|
−
|style="background-color:#F0F8FF"|[[Uterine cancer]]
+
|style="background-color:#F0F8FF"|
 +
|style="background-color:#F0F8FF"|
 
|-
 
|-
 
|colspan="4" style="background-color:#93cdff"|'''Site-agnostic'''
 
|colspan="4" style="background-color:#93cdff"|'''Site-agnostic'''
Line 82: Line 136:
 
|style="background-color:#F0F8FF"|
 
|style="background-color:#F0F8FF"|
 
|-
 
|-
 +
|}
 +
<span id="malignantheme"></span>
 +
{| class="wikitable" style="float:right; margin-left: 5px;"
 +
|-
 +
|[[#top|back to top]]
 +
|}
 +
{| border="1" style="text-align:center; margin-left: auto; margin-right: auto; font-weight: bold; width: 100%;"
 
!colspan="4" align="center" style="color:white; font-size:150%; background-color:#FF0D00"| '''Malignant Hematology'''
 
!colspan="4" align="center" style="color:white; font-size:150%; background-color:#FF0D00"| '''Malignant Hematology'''
 
|-
 
|-
 
|colspan="4" style="background-color:#ff9e99"|'''Acute leukemias'''
 
|colspan="4" style="background-color:#ff9e99"|'''Acute leukemias'''
 
|-
 
|-
−
|style="background-color:#FFF0F5"|[[Acute myeloid leukemia | Acute myeloid leukemia (AML)]]
+
|style="width: 25%; background-color:#FFF0F5"|[[Acute myeloid leukemia | Acute myeloid leukemia (AML)]]
−
|style="background-color:#FFF0F5"|[[Acute promyelocytic leukemia | Acute promyelocytic leukemia (APL)]]
+
|style="width: 25%; background-color:#FFF0F5"|[[Acute promyelocytic leukemia | Acute promyelocytic leukemia (APL)]]
−
|style="background-color:#FFF0F5"|[[B-cell acute lymphoblastic leukemia | B-cell acute lymphoblastic leukemia (B-ALL)]]
+
|style="width: 25%; background-color:#FFF0F5"|[[B-cell acute lymphoblastic leukemia | B-cell acute lymphoblastic leukemia (B-ALL)]]
−
|style="background-color:#FFF0F5"|[[T-cell acute lymphoblastic leukemia | T-cell acute lymphoblastic leukemia/lymphoma (T-ALL/T-LBL)]]
+
|style="width: 25%; background-color:#FFF0F5"|[[T-cell acute lymphoblastic leukemia | T-cell acute lymphoblastic leukemia/lymphoma (T-ALL/T-LBL)]]
 
|-
 
|-
 
|style="background-color:#FFF0F5"|[[CNS leukemia]]
 
|style="background-color:#FFF0F5"|[[CNS leukemia]]
Line 145: Line 206:
 
|style="background-color:#FFF0F5"|
 
|style="background-color:#FFF0F5"|
 
|-
 
|-
 +
|}
 +
<span id="otherheme"></span>
 +
{| class="wikitable" style="float:right; margin-left: 5px;"
 +
|-
 +
|[[#top|back to top]]
 +
|}
 +
{| border="1" style="text-align:center; margin-left: auto; margin-right: auto; font-weight: bold; width: 100%;"
 
|colspan="4" align="center" style="color:white; font-size:150%; background-color:#228B22"|'''Other Hematology'''
 
|colspan="4" align="center" style="color:white; font-size:150%; background-color:#228B22"|'''Other Hematology'''
 
|-
 
|-
−
|style="background-color:#F0FFF0"|[[Aplastic anemia]]
+
|style="width: 25%; background-color:#F0FFF0"|[[Aplastic anemia]]
−
|style="background-color:#F0FFF0"|[[Atypical hemolytic-uremic syndrome (aHUS)]]
+
|style="width: 25%; background-color:#F0FFF0"|[[Atypical hemolytic-uremic syndrome (aHUS)]]
−
|style="background-color:#F0FFF0"|[[Autoimmune cytopenias]]
+
|style="width: 25%; background-color:#F0FFF0"|[[Autoimmune cytopenias]]
−
|style="background-color:#F0FFF0"|[[Autoimmune thrombocytopenic purpura (ITP)]]
+
|style="width: 25%; background-color:#F0FFF0"|[[Autoimmune thrombocytopenic purpura (ITP)]]
 
|-
 
|-
 
|style="background-color:#F0FFF0"|[[Castleman disease]]
 
|style="background-color:#F0FFF0"|[[Castleman disease]]
Line 169: Line 237:
 
|}
 
|}
  
−
<big>'''[[Special:AllPages|Browse our complete index of pages]]'''</big>
+
<div style="text-align:center"><big>'''[[Special:AllPages|Browse our complete index of pages]]'''</big></div>
  
 +
==Additional Information==
 
Created as a knowledge base for hematology & oncology providers, HemOnc.org is a collaborative wiki containing details about 100s of hematology/oncology drugs, and 1000s of antineoplastic regimens. Content is added by hematology & oncology providers, and undergoes [[how to contribute|continuous peer review]].
 
Created as a knowledge base for hematology & oncology providers, HemOnc.org is a collaborative wiki containing details about 100s of hematology/oncology drugs, and 1000s of antineoplastic regimens. Content is added by hematology & oncology providers, and undergoes [[how to contribute|continuous peer review]].
  

Revision as of 12:34, 3 October 2017

HemOnc.org - A Free Hematology/Oncology Reference

Regimens: 4,428 Regimen variants: 6,546
Jump to: Solid Tumors Malignant Hematology Other Hematology
Editorial Board
Disease index Drug index Regimen index General reference
Desktop Version Mobile Version Mobile shortcut Fellowship programs
If this is your first time visiting, please go to the tutorial page or just start exploring!

Links to Main Disease Pages

Solid Tumors
Breast Oncology
Breast cancer Breast cancer, HER-2 positive
Dermatologic Oncology
Melanoma Skin, basal & squamous cancer Merkel cell carcinoma
Endocrine Oncology
Germ cell tumors Neuroendocrine tumors Thyroid cancer
Gastrointestinal Oncology
Anal cancer Colon cancer Esophageal cancer Gastric cancer
Gastrointestinal stromal tumor (GIST) Hepatobiliary cancer Pancreatic cancer Rectal cancer
Genitourinary Oncology
Bladder cancer Germ cell tumors Penile cancer Prostate cancer
Renal cancer (RCC) Testicular cancer
Gynecologic Oncology
Cervical cancer Germ cell tumors Ovarian cancer Uterine cancer
Head & Neck Oncology
Head and neck cancer Thyroid cancer
Neuro-Oncology
Central nervous system (CNS) cancer Glioblastoma CNS leukemia CNS lymphoma
Pediatric Oncology
Neuroblastoma
Sarcoma
Bone cancer Ewing's sarcoma Gastrointestinal stromal tumor (GIST) Osteosarcoma
Sarcoma
Thoracic Oncology
Esophageal cancer Lung cancer, non-small cell (NSCLC) Lung cancer, small cell (SCLC) Mesothelioma
Thymoma
Site-agnostic
MSI-H or dMMR Unknown primary

back to top
Malignant Hematology
Acute leukemias
Acute myeloid leukemia (AML) Acute promyelocytic leukemia (APL) B-cell acute lymphoblastic leukemia (B-ALL) T-cell acute lymphoblastic leukemia/lymphoma (T-ALL/T-LBL)
CNS leukemia Transplant conditioning regimens
Myeloproliferative neoplasms and myelodysplastic syndromes
Chronic myelogenous leukemia (CML) Chronic myelomonocytic leukemia (CMML) Essential thrombocythemia (ET) Hypereosinophilic syndrome (HES)
Myelodysplastic syndrome Primary & secondary myelofibrosis Polycythemia vera (PV) Systemic mastocytosis
Mature B-, T-, and NK-cell neoplasms
Adult T-cell leukemia-lymphoma (ATLL) Anaplastic large cell lymphoma (ALCL) Burkitt lymphoma (BL) or Burkitt-like lymphoma Chronic lymphocytic leukemia (CLL/SLL)
CNS lymphoma Cutaneous T-cell lymphoma (CTCL) Diffuse large B-cell lymphoma (DLBCL) Extranodal NK/T-cell lymphoma, nasal type
Follicular lymphoma (FL) Hairy cell leukemia (HCL) HIV-associated lymphoma Hodgkin lymphoma (HL)
Hodgkin lymphoma, nodular lymphocyte-predominant (NLP-HL) Large granular lymphocytic (LGL) leukemia Light-chain (AL) amyloidosis Mantle cell lymphoma (MCL)
Marginal zone lymphoma (MZL) Mediastinal gray-zone lymphoma (MGZL) Multiple myeloma (MM) NK/T-cell lymphoma
Peripheral T-cell Lymphoma (PTCL) Plasma cell leukemia Post-transplant lymphoproliferative disorder (PTLD) Primary mediastinal B-cell lymphoma (PMBL)
Transformed lymphoma (TL) Transplant conditioning regimens Waldenström macroglobulinemia (WM/LPL)

back to top
Other Hematology
Aplastic anemia Atypical hemolytic-uremic syndrome (aHUS) Autoimmune cytopenias Autoimmune thrombocytopenic purpura (ITP)
Castleman disease Coagulopathies Cold agglutinin disease Hemophagocytic lymphohistiocytosis (HLH)
Histiocytoses Paroxysmal nocturnal hemoglobinuria (PNH) Sickle cell anemia Thrombotic thrombocytopenic purpura (TTP)
Venous thromboembolism (VTE)
Browse our complete index of pages

Additional Information

Created as a knowledge base for hematology & oncology providers, HemOnc.org is a collaborative wiki containing details about 100s of hematology/oncology drugs, and 1000s of antineoplastic regimens. Content is added by hematology & oncology providers, and undergoes continuous peer review.


Any information that one feels would be helpful to other oncology providers is welcome. Visit how to contribute for more details. Priorities of this project include:

  1. Creating a database of chemotherapy agents and other medications.
  2. Creating a database of chemotherapy regimens and references to primary literature (PubMed and direct links to the abstracts/full articles).
  3. Sample order sets and examples of supportive medications used with treatment regimens
  4. Aggregating useful links to existing resources by disease, such as information about prognosis, clinical calculators, staging, and patient resources.

Additional possibilities for this project may include:

  1. Creating summaries of pivotal clinical trials
  2. Establishing homepages for ongoing clinical trials that contain information and sites of participation
  3. Checklists for common clinical scenarios/diseases
  4. Creating checklists that can be used for patients starting therapy with particular regimens, such as laboratory & imaging (e.g. echocardiogram, PFTs) parameters to monitor and informed consent/discussion of side effects

The field of hematology/oncology is ever-changing, and our hope is that other people will be interested in contributing to make it an increasingly more useful resource. The rapidly evolving nature of the practice demands a more dynamic medium than existing resources can provide and would benefit from being able to be updated in real-time from virtually any computer with internet access. We believe that the familiar format of a Wiki, made popular by sites such as Wikipedia, will significantly help ease-of-use and navigation.

Retrieved from "https://hemonc.org/w/index.php?title=Main_Page&oldid=17695"